what is glp 1 drug The GLP-1 revolution: UAB researchers are discovering about how these drugs work GLP-1 Drugs & What They

However, a database analysis of nearly 200,000 individuals treated with GLP-1RAs for diabetes, obesity or both identified a discontinuation rate of 36.5% at 12 months (30)

Raz I, Wiviott SD, Yanuv I, et al

To our knowledge, only one trial on the efficacy of the combination of multiple agonists in the treatment of NAFLD in humans is available to date

*Correspondence: Frederik Flindt Kreiner, [email protected] This article was submitted to Clinical and Translational Physiology, a section of the journal Frontiers in Physiology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

However, most of these studies used standard doses approved for diabetes or obesity, and dedicated trials examining low-dose GLP-1 specifically for inflammatory conditions are lacking